Total Current Liabilities

$12.38M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$12.38Mperiod endingJun 30, 2026

PDSB Quarterly Current Liabilities ($3.89M → $12.38M)

Quarterly total current liabilities

High-resolution chart · PNG

PDSB total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PDS Biotechnology Corporation Total Current Liabilities — Quarterly (USD)
Period ending	Total Current Liabilities (USD)
Jun 30, 2026	12,377,476
Mar 31, 2026	10,146,725
Dec 31, 2025	9,483,214
Sep 30, 2025	13,329,460
Jun 30, 2025	11,531,452
Mar 31, 2025	18,265,345
Dec 31, 2024	17,087,201
Sep 30, 2024	18,340,203
Jun 30, 2024	15,674,774
Mar 31, 2024	15,063,690
Dec 31, 2023	13,629,977
Sep 30, 2023	9,153,828
Jun 30, 2023	7,904,189
Mar 31, 2023	4,129,540
Dec 31, 2022	9,821,036
Sep 30, 2022	4,841,142
Jun 30, 2022	4,515,924
Mar 31, 2022	5,018,488
Dec 31, 2021	3,756,031
Sep 30, 2021	3,577,148
Jun 30, 2021	4,002,818
Mar 31, 2021	2,929,047
Dec 31, 2020	3,270,450
Sep 30, 2020	2,898,604
Jun 30, 2020	2,526,404
Mar 31, 2020	4,046,781
Dec 31, 2019	2,793,545
Sep 30, 2019	3,643,899
Jun 30, 2019	4,267,453
Mar 31, 2019	5,538,124
Dec 31, 2018	6,381,752
Sep 30, 2018	6,688,287
Jun 30, 2018	13,869,512
Mar 31, 2018	32,330,165
Dec 31, 2017	12,866,759
Sep 30, 2017	11,701,979
Jun 30, 2017	11,590,468
Mar 31, 2017	6,745,759
Dec 31, 2016	6,684,747
Sep 30, 2016	4,253,599
Jun 30, 2016	6,763,927
Mar 31, 2016	6,570,690
Dec 31, 2015	8,589,708
Sep 30, 2015	8,450,143
Jun 30, 2015	4,029,812
Dec 31, 2014	3,893,209